🇮🇳June 16, 2026·13h agoIndustry

natco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26

Publisher

Natco Pharma

India

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: Natco Pharma
Region: India
Scope: Industry
Published: June 16, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on natcopharma.co.in

Leave the platform to read the original full article on the publisher site.

Source: Natco Pharma

Scope: Industry

Open original article

Related coverage

More related coverage

Recordati·2h ago

RECORDATI CELEBRATES ITS FIRST 100 YEARS AT TRIENNALE MILANO WITH AN EXHIBITION REVEALING OBJECTS AND IMAGES FROM ITS HISTORICAL ARCHIVE FOR THE FIRST TIME

Farmak (Ukraine)·2h ago

Ukrainian Physicians Visit ICM Farmak Plant in Spain for the First Time

Monash Health·8h ago

Update on Maternity, Newborn and Gynaecology Services at Sandringham Hospital

Natco Pharma·13h ago

natco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26